A Nationwide Post-Marketing Study on the Safety of Abatacept Treatment in Sweden Using the SRQ Register

25/09/2019
14/03/2024
EU PAS number:
EUPAS31529
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information